Description

Mebicar IC (mebicar) tablets 0.5 g. №20

Ingredients

Active ingredient: Mebicar 0.5 g per tablet.

Dosage

Recommended dosage: The usual dose is 0.5-1 g 2-3 times a day. Consult a healthcare professional for personalized dosing instructions.

Indications

Mebicar IC tablets are indicated for the treatment of anxiety, neurosis, adjustment disorders, and other conditions where an anxiolytic effect is needed.

Contraindications

Do not use Mebicar IC tablets if you are allergic to mebicar or any other ingredients in the product. It is also contraindicated in pregnant and lactating women.

Directions

Take Mebicar IC tablets orally with water. Do not exceed the recommended dosage. Follow the instructions provided by your healthcare provider.

Scientific Evidence

Mebicar, the active ingredient in Mebicar IC tablets, has been studied for its anxiolytic effects. Research published in the journal “Neuroscience and Behavioral Physiology” demonstrated the efficacy of mebicar in reducing anxiety levels in patients. The study concluded that mebicar showed significant anxiolytic activity without causing sedation or muscle relaxation.

Additional Information

Mebicar is known for its favorable tolerability profile and low risk of side effects compared to other anxiolytic medications. It works by modulating the GABAergic system in the brain, which helps regulate anxiety and stress responses. Clinical trials have shown that mebicar is well-tolerated and effective in managing anxiety symptoms.

Overall, Mebicar IC tablets offer a safe and effective option for individuals suffering from anxiety disorders. The medication’s mechanism of action, supported by scientific evidence, makes it a valuable choice in the treatment of anxiety-related conditions.

Consult your healthcare provider to determine if Mebicar IC tablets are suitable for your condition and to receive personalized treatment recommendations.